Works matching IS 0167594X AND DT 2024 AND VI 166 AND IP 3
Results: 19
A systematic review of the impact of brain tumours on risk of motor vehicle crashes.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 395, doi. 10.1007/s11060-024-04586-6
- By:
- Publication type:
- Article
Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 379, doi. 10.1007/s11060-024-04584-8
- By:
- Publication type:
- Article
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 547, doi. 10.1007/s11060-024-04580-y
- By:
- Publication type:
- Article
Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 535, doi. 10.1007/s11060-024-04578-6
- By:
- Publication type:
- Article
The relationship between pathological brain activity and functional network connectivity in glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 523, doi. 10.1007/s11060-024-04577-7
- By:
- Publication type:
- Article
Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 569, doi. 10.1007/s11060-024-04574-w
- By:
- Publication type:
- Article
Utility of contrast-enhanced MRI radiomics features combined with clinical indicators for predicting induction chemotherapy response in primary central nervous system lymphoma.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 451, doi. 10.1007/s11060-023-04554-6
- By:
- Publication type:
- Article
MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 513, doi. 10.1007/s11060-024-04573-x
- By:
- Publication type:
- Article
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 557, doi. 10.1007/s11060-023-04544-8
- By:
- Publication type:
- Article
The importance of considering competing risks in recurrence analysis of intracranial meningioma.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 503, doi. 10.1007/s11060-024-04572-y
- By:
- Publication type:
- Article
Whole-exome sequencing reveals genetic variants that may play a role in neurocytomas.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 471, doi. 10.1007/s11060-024-04567-9
- By:
- Publication type:
- Article
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 461, doi. 10.1007/s11060-024-04562-0
- By:
- Publication type:
- Article
GammaTile<sup>®</sup> (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 441, doi. 10.1007/s11060-023-04545-7
- By:
- Publication type:
- Article
Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 493, doi. 10.1007/s11060-024-04571-z
- By:
- Publication type:
- Article
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 485, doi. 10.1007/s11060-024-04568-8
- By:
- Publication type:
- Article
Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 431, doi. 10.1007/s11060-023-04543-9
- By:
- Publication type:
- Article
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 419, doi. 10.1007/s11060-023-04535-9
- By:
- Publication type:
- Article
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 407, doi. 10.1007/s11060-023-04513-1
- By:
- Publication type:
- Article